Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP295 (RN7SK pseudogene 295) is a *pseudogene* related to the small nuclear RNA gene RN7SK, itself a non-coding RNA implicated in transcriptional regulation by sequestering and inhibiting the positive transcription elongation factor b (P-TEFb)[7]. The RN7SK gene product is a critical regulatory lncRNA, but *pseudogenes* like RN7SKP295 are non-functional gene copies: they do not produce functional RNA or proteins and are not receptors, enzymes, or drug targets. No therapeutic or biomarker roles have been defined for RN7SKP295[7]. If you are seeking information about the functional RN7SK RNA, more detail can be provided, but RN7SKP295 itself has no known biological role, drug target status, or clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 295 (RN7SKP295).